ARCHIVES

Proof of principle needed before launching “big science” program, advisors say.

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | March 11, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For CLL

February 19, 2010

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999

Gore, Agency Report, Support Legislation To Protect Genetic Info

January 30, 1998

In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick

September 23, 1983

NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial

February 14, 1986